OTC Markets OTCQX - Delayed Quote USD

Optimi Health Corp. (OPTHF)

Compare
0.1650 +0.0050 (+3.13%)
As of 9:30 AM EDT. Market Open.
Loading Chart for OPTHF
DELL
  • Previous Close 0.1600
  • Open 0.1650
  • Bid 0.1400 x --
  • Ask 0.1610 x --
  • Day's Range 0.1650 - 0.1650
  • 52 Week Range 0.1100 - 0.4300
  • Volume 2,500
  • Avg. Volume 21,666
  • Market Cap (intraday) 15.749M
  • Beta (5Y Monthly) 1.28
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Optimi Health Corp. engages in the research, cultivation, processing, extraction, and distribution of psilocybin, psilocin, other psychedelic substances, and functional mushrooms for health and wellness markets in Canada and internationally. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of fungi varieties, including Lion's Mane, Chaga, Reishi, Turkey Tail, and Cordyceps. It sells its products through www.optimilife.com, an e-commerce website platform; and Amazon marketplace, and distributors/brokers. The company was formerly known as 1251418 BC Ltd. and changed its name to Optimi Health Corp. in August 2020. Optimi Health Corp. was incorporated in 2020 and is based in Garibaldi Highlands, Canada.

www.optimihealth.ca

--

Full Time Employees

September 30

Fiscal Year Ends

Recent News: OPTHF

View More

Performance Overview: OPTHF

Trailing total returns as of 11/1/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

OPTHF
11.53%
S&P/TSX Composite index
15.68%

1-Year Return

OPTHF
31.89%
S&P/TSX Composite index
28.45%

3-Year Return

OPTHF
68.27%
S&P/TSX Composite index
15.24%

5-Year Return

OPTHF
71.04%
S&P/TSX Composite index
27.42%

Compare To: OPTHF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: OPTHF

View More

Valuation Measures

Annual
As of 10/31/2024
  • Market Cap

    14.63M

  • Enterprise Value

    16.35M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    76.45

  • Price/Book (mrq)

    1.80

  • Enterprise Value/Revenue

    90.48

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -21.27%

  • Return on Equity (ttm)

    -45.46%

  • Revenue (ttm)

    351.92k

  • Net Income Avi to Common (ttm)

    -5.64M

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    245.84k

  • Total Debt/Equity (mrq)

    25.26%

  • Levered Free Cash Flow (ttm)

    -3.1M

Research Analysis: OPTHF

View More

Company Insights: OPTHF

Research Reports: OPTHF

View More

People Also Watch